Asp-AMS is a potent inhibitor of aspartyl-tRNA synthetase (AspRS) and mitochondrial enzyme, exhibiting nanomolar-range Ki values; it shows stronger inhibitory activity against bacterial AspRSs (e.g., E. coli and P. aeruginosa) than human cytosolic AspRS, and is the most effective inhibitor of the mitochondrial enzyme, with 500-fold greater potency than aspartol-AMP (IC50 = 10 nM) and 35-fold lower inhibition of human and bovine cytosolic AspRSs (IC50 = 300 nM).